ALPHAEON Corporation Raises $77 Million Through the Sale of Four Million Shares in Evolus Inc.

On May 20th, Stradling client ALPHAEON Corporation completed the sale of four million shares of common stock of Evolus, Inc. (NASDAQ: EOLS) in an underwritten public offering with Morgan Stanley as sole underwriter for the offering, yielding $77 million in net proceeds. 

ALPHAEON Corporation is a company focused on developing and bringing to market highly innovative healthcare products and services. EVOLUS is a performance beauty company with a customer-centric approach focused on delivering breakthrough products.